Common and cell-type specific responses to anti-cancer drugs revealed by high throughput transcript profiling
Understanding why some tumor cells respond to therapy and others do not is essential for advancing precision cancer care. Here, the authors perform large-scale transcriptomic profiling of breast cancer cell lines treated with anti-cancer drugs and find that certain drug classes induce cell line spec...
Guardado en:
Autores principales: | Mario Niepel, Marc Hafner, Qiaonan Duan, Zichen Wang, Evan O. Paull, Mirra Chung, Xiaodong Lu, Joshua M. Stuart, Todd R. Golub, Aravind Subramanian, Avi Ma’ayan, Peter K. Sorger |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/57f6fd3a402544048badc526067a421b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Construction and validation of a regulatory network for pluripotency and self-renewal of mouse embryonic stem cells.
por: Huilei Xu, et al.
Publicado: (2014) -
The logic of EGFR/ErbB signaling: theoretical properties and analysis of high-throughput data.
por: Regina Samaga, et al.
Publicado: (2009) -
Transcriptome analysis of human dermal fibroblasts following red light phototherapy
por: Evan Austin, et al.
Publicado: (2021) -
SIRT6 haploinsufficiency induces BRAFV600E melanoma cell resistance to MAPK inhibitors via IGF signalling
por: Thomas Strub, et al.
Publicado: (2018) -
Massive mining of publicly available RNA-seq data from human and mouse
por: Alexander Lachmann, et al.
Publicado: (2018)